Peer-Reviewed Studies
Key Studies on Trans Feminine HRT
| Study | Year | Key Findings |
|---|---|---|
| de Blok CJM, et al. — Breast cancer risk in transgender people receiving hormone treatment (BMJ) | 2019 | Trans women have ~47× higher breast cancer risk than cis men, but ~3× lower than cis women |
| Nota NM, et al. — Occurrence of acute cardiovascular events (Circulation) | 2019 | Low absolute risk of cardiovascular events in trans women on HRT |
| Connelly PJ, et al. — Managing VTE risk in transgender adults | 2021 | Transdermal estradiol has lower VTE risk than oral |
| Weill A, et al. — CPA and meningioma risk (BMJ) | 2021 | Dose-dependent meningioma risk with CPA |
Key Studies on Trans Masculine HRT
| Study | Year | Key Findings |
|---|---|---|
| van Velzen DM, et al. — Long-term effects of T therapy | 2021 | T therapy is safe with appropriate monitoring |
| Gava G, et al. — Metabolic effects of T therapy | 2020 | Minimal adverse metabolic effects in healthy individuals |
Clinical Guidelines
| Guideline | Year | Publisher |
|---|---|---|
| WPATH SOC8 | 2022 | WPATH |
| Endocrine Society Guidelines | 2017 | Endocrine Society |
| UCSF Transgender Care Guidelines | 2016 | UCSF |
How to Access Studies
- PubMed (pubmed.ncbi.nlm.nih.gov) — Free abstracts; some free full text
- Sci-Hub — Free access to paywalled papers
- Google Scholar (scholar.google.com) — Free search
References
de Blok CJM, et al. (2019). BMJ. https://www.bmj.com/content/365/bmj.l1652
Nota NM, et al. (2019). Circulation. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.038584
Weill A, et al. (2021). BMJ. https://www.bmj.com/content/372/bmj.n37